CHAT and Alzheimer disease: The plasma ChAT protein concentration was significantly higher in the AD patients, i.e., by 198 ± 22% compared to the MCI-group (p < 0.0006) and 245 ± 14% higher than the SCI-group (p < 0.0001, Figure 2B).